CD200 and uveal melanoma: Uveal melanoma can evade immune surveillance via multiple mechanisms, such as inhibitory checkpoint programmed cell death ligand 1 (PD-L1), cluster of differentiation 47 (CD47), and cluster of differentiation 200 (CD200) [103].